Borderline Disorders

  • Paul H. Soloff


Definition of borderline disorder and its place in psychiatric nomenclature remain controversial topics. Historically, psychoanalytic psychiatrists used the term to define a “borderland” between neurotic and psychotic functioning where patients manifested primitive character styles, impulsive behavior, and disturbed interpersonal relations .1 The disorder was considered either a severe neurosis, a transitional prepsychotic disorder, or an infantile, impulse-ridden personality disorder. In the course of psychoanalytic treatment for various neurotic complaints, these patients would at times have difficulty reality testing, regress, and develop “transference psychoses.” In everyday life, they manifested “micropsychotic” episodes in response to specific psychodynamic stressors. These episodes were generally characterized by brief periods of referential thinking and paranoid ideation but responded to structure and direction from the therapist.


Depressed Mood Personality Disorder Impulsive Behavior Borderline Personality Disorder Rejection Sensitivity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mack J. E.: Borderline states: An historical perspective, in Mack J. E. (ed): Borderline States in Psychiatry. New York, Grune & Stratton, 1975, pp 1–28.Google Scholar
  2. 2.
    Grinker R. R. Sr., Werble B., Drye R. C.: The Borderline Syndrome. New York, Basic Books, 1968.Google Scholar
  3. 3.
    Spitzer R. L., Endicott J., Gibbon M.: Crossing the border into borderline personality and borderline schizophrenia: The development of criteria. Arch Gen Psychiatry 36:17–24, 1979.PubMedCrossRefGoogle Scholar
  4. 4.
    Gunderson J. G., Kolb J. E., Austin V. : The diagnostic interview for borderline patients. Am J Psychiatry 138:895–903, 1981.Google Scholar
  5. 5.
    Perry J.: The Borderline Personality Disorder Scale. Cambridge, MA, Cambridge Hospital, 1982.Google Scholar
  6. 6.
    Sheehy M., Goldsmith L., Charles E.: A comparative study of borderline patients in a psychiatric outpatient clinic. Am J Psychiatry 137:1374–1379, 1980.PubMedGoogle Scholar
  7. 7.
    Soloff P. H.: Pharmacotherapy of borderline disorders. Compr Psychiatry 22:535–543, 1981.PubMedCrossRefGoogle Scholar
  8. 8.
    Andrulonis P. A., Glueck B. C., Stroebel C. F., et al: Organic brain dysfunction and the borderline syndrome. Psychiatr Clin North Am 4:61–66, 1981.Google Scholar
  9. 9.
    Swartz M., Blazer D., George L., et al.: Estimating the Prevalence of Borderline Personality Disorder in the Community. J. Personality Disorders 4(3): 257–272, 1990.CrossRefGoogle Scholar
  10. 10.
    Pope H. G., Jonas J. M., Hudson J. I., et al: The validity of DSM-III borderline personality disorder. Arch Gen Psychiatry 40:23–30, 1983.PubMedCrossRefGoogle Scholar
  11. 11.
    Baxter L., Edell W., Gerner R., et al: Dexamethasone suppression test and axis I diagnoses of inpatients with DSM-III borderline disorder. J Clin Psychiatry 45:150–153, 1984.PubMedGoogle Scholar
  12. 12.
    Soloff P. H., George A., Nathan R. S., et al: Characterizing depression in borderline patients. J Clin Psychiatry 48:155–157, 1987.PubMedGoogle Scholar
  13. 13.
    Soloff P. H., George A., Nathan R. S.: The dexamethasone suppression test in patients with borderline personality disorder. Am J Psychiatry 139:1621–1623, 1982.PubMedGoogle Scholar
  14. 14.
    Nathan R. S., Soloff P. H., George A., et al: DST and TRH in borderline personality disorder, in Shagass C., Josiassen R., Bridger W. H., et al (eds): Biological Psychiatry, 1985. New York: Elsevier, 1986, pp 563–565.Google Scholar
  15. 15.
    Soloff P. H., George A., Nathan R. S., et al: Progress in pharmacotherapy of borderline disorders. Arch Gen Psychiatry 43:691–697, 1986.PubMedCrossRefGoogle Scholar
  16. 16.
    Akiskal H. S.: Subaffective disorders: Dysthymic, cyclothymic and bipolar II disorders in the “borderline” realm. Psychiatr Clin North Am 4:25–60, 1981.PubMedGoogle Scholar
  17. 17.
    Liebowitz M. R., Klein D. F.: Hysteroid dysphoria. Psychiatr Clin North Am 2:555–575, 1979.Google Scholar
  18. 18.
    Gardner D. L., Cowdry R. W.: Development of melancholia during carbamazepine treatment in borderline personality disorder. J Clin Psychopharmacol 6:236–239, 1986.PubMedCrossRefGoogle Scholar
  19. 19.
    Soloff P. H., George A., Nathan R. S., et al: Patterns of response among borderline patients with amitriptyline and haloperidol. Presented at the NCDEU meeting, Key Biscayne, FL, May 1987.Google Scholar
  20. 20.
    George A., Soloff P. H.: Schizotypal symptoms in patients with borderline personality disorders. Am J Psychiatry 143:212–215, 1986.PubMedGoogle Scholar
  21. 21.
    Cornelius J. R., Brenner R. P., Soloff P. H., et al: EEG abnormalities in borderline personality disorder: Specific or non-specific. Biol Psychiatry 21:974–977, 1986.CrossRefGoogle Scholar
  22. 22.
    Cornelius J. R., Schulz S. C., Brenner R. P., et al: Changes in EEG mean frequency associated with anxiety and amphetamine challenge in BPD. Presented at the 41st Annual Meeting of the Society of Biological Psychiatry, Chicago, May, 1986.Google Scholar
  23. 23.
    Gardner D. L., Cowdry R. W. : Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder. Am J Psychiatry 143:519–522, 1986.PubMedGoogle Scholar
  24. 24.
    Gardner D. L., Cowdry R. W.: Alprazolam-induced dyscontrol in borderline personality disorder. Am J Psychiatry 142:98–100, 1985.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Paul H. Soloff
    • 1
    • 2
  1. 1.Department of PsychiatryUniversity of PittsburghPittsburghUSA
  2. 2.Western Psychiatric Institute and ClinicPittsburghUSA

Personalised recommendations